Nomegestrol
This article is about a non-clinically used progestin compound. For the pharmaceutical drug, see nomegestrol acetate.
 | |
| Clinical data | |
|---|---|
| ATC code | G03DB04 (WHO) |
| Identifiers | |
| |
| CAS Number | 58691-88-6 |
| PubChem (CID) | 68783 |
| ChemSpider | 62024 |
| KEGG | D07222 |
| Chemical and physical data | |
| Formula | C21H28O3 |
| Molar mass | 328.445 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Nomegestrol (INN), also known as 19-normegestrol, is a steroidal progestin which was patented in 1975 but was never marketed.[1][2] It is the parent compound of nomegestrol acetate, which is marketed as a progestin.[1][2]
See also
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 883–. ISBN 978-1-4757-2085-3.
- 1 2 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 747–. ISBN 978-3-88763-075-1.
| AR |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GPRC6A |
| ||||||||||
See also: Estrogenics • Glucocorticoidics • Mineralocorticoidics • Progestogenics • Steroid hormone metabolism modulators • List of androgens/anabolic steroids | |||||||||||
This article is issued from Wikipedia - version of the 10/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.